AssetID: 55180831
Headline: UNCAPTIONED: FDA Clears Blood Test To Help Rule Out Alzheimer's Disease
Caption: FDA Clears Blood Test To Help Rule Out Alzheimer’s Disease. The US Food and Drug Administration has cleared a new blood test to help assess Alzheimer’s disease and other causes of cognitive decline.Developed by Roche Diagnostics in collaboration with Eli Lilly, the Elecsys pTau181 test is designed for adults aged 55 and older showing signs or symptoms of cognitive issues. The test allows primary care physicians to identify patients who are unlikely to have Alzheimer’s, while those with a positive result can be referred for further testing. Brad Moore, president of Roche Diagnostics North America, said the test will help patients and clinicians get answers sooner, supporting earlier care. Dementia affects an estimated 42% of Americans over 55, yet around 92% of adults with mild cognitive impairment go undiagnosed. Dr Joanne Pike, president of the Alzheimer’s Association, described the FDA approval as “another important step toward expanding access to Alzheimer’s disease diagnostic tools,” offering hope for earlier intervention and improved management for millions of patients. Instructions: THIS VIDEO MUST NOT BE EDITED FOR LENGTH TO COMBINE WITH OTHER CONTENT
Keywords: Health & Wellbeing,FDA,US Food and Drug Administration,cleared,new,blood test,help,assess,Alzheimer’s disease,cognitive decline,Roche diagnostics,Eli Lilly,Elecsys pTau 181,adults,55 and older,signs,symptoms,issues
PersonInImage: